Hepatitis C virus infection in Italian kidney graft recipients. Changing risk factors and hepatitis C virus genotypes

Italian Journal of Gastroenterology and Hepatology

Volumn 29, Issue 5, 1997, Pages 448-455

  Angelico, M ^a   Tisone, G ^a   Rapicetta, M ^b   Pisani, F ^c   Gandin, C ^b   Chionne, P ^c   Dettori, S ^a   Laria, G ^a   Danese, V ^a   Orlando, G ^a   Casciani, C U ^b  

^a Dept of Surgery and Transplant Centre ^*  (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Haemodialysis; HCV genotypes; Immunosuppression; Kidney transplantation

Indexed keywords

CYCLOSPORIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; VIRUS RNA;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; BIOCHEMISTRY; DEVELOPING COUNTRY; DISEASE DURATION; EUROPE; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; ITALY; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR;

ADULT; AGED; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; ITALY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RISK FACTORS; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES;

EID: 18544391367     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Suthanthiran M, Strom TB. Renal transplantation. N Engl J Med 1994;331:365-76.
2. Lau JYN, Davis GL, Brunson ME, Qian K-P, Lin H-J, Quan S, et al. Hepatitis C virus infection in kidney transplant recipients. Hepatology 1993:18:1027-31.
3. Zeldis JB, Depner TA, Kuramoto IK, Gish RG, Holland PV. The prevalence of hepatitis C virus antibodies among hemodialysis patients. Ann Int Med 1990; 12:958-60.
4. Dentico P, Volpe A, Buongiomo R, Fiore G, Carbone M, Manno C. Detection of antibodies to HCV in haemodialysis patients using two second generation ELISA tests. Ital J Gastroenterol 1993;25:19-22.
5. Donahue JG, Munoz A, Ness PM, Brown DE, Yawn DH, McAllister HA, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992;327:369.
6. Pereira BJG, Milford EL, Kirkman RL, Quan S, Sayre KR, Johnson PJ, et al. Prevalence of hepatitis C virus RNA in organ donor positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med 1992;337:910-5.
7. Irie Y, Hayashi H, Yokozeki K, Kashima T, Okuda K. Hepatitis C infection unrelated to blood transfusion in hemodialysis patients. JHepatol 1994;20:557-9.
8. Roth D, Miller J. Transmission of hepatitis C virus by organ transplantation. Clin Transplant 1993;7:93-5.
9. Huang C-C, Liaw Y-F, Lai M-K, Chu S-H, Chuang C-K, Huang J-Y. The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients. Transplantation 1992;53:763-5.
10. Pereira BJG, Wright T, Schmid CH, Levey AS. The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation. Transplantation 1995;60:799-805.
11. Simmonds P. Variability of hepatitis C virus. Hepatology 1995;21:570-83.
12. Pol S, Thiers V, Nousbaum J-B, Legendre C, Berthelot P, Kreis H, et al. The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology 1995;108:581-3.
13. Rapicetta M, Attili AF, Mêle A, De Santis A, Chionne P, Cristiano K, et al. Prevalence of hepatitis C virus antibodies and hepatitis C virus-RNA in an urban population. J Med Virol 1992:37:87-92.
14. Okamoto H, Tokita H, Sakamoto M, Horikita M, Kojima M, Hzuka H, et al. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 1993;74:2385-90.
15. Cheng IKP, Chan DTM, Lok ASF. Hepatitis C infection among renal transplant recipients: a comparative study using first- and second-generation anti-HCV EIA and HCV detection by nested PCR. Transplant Proc 1993 ;25:1460-2.
16. Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 1995;21:285-90.
17. Nousbaum J, Pol S, Nalpas B, Landais P, Berthelot P, Brechet C and the Collaborative Study Group. Hepatitis C virus type Ib (II) infection in France and Italy. Ann Intern Med 1995;122:161-8.
18. Zeuzem S, Franke A, Lee J-H, Herrmann G, Rüster B, Roth WK. Phylogenetic analysis of hepatitis isolates and their correlation to
19. viremia, liver function tests, and histology. Hepatology 1996;24:1003-9.
20. Zhou S, Terrault NA, Ferrel L, Hahn JA, Lau JYN, Simmonds P, et al. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology 1996;24:1041-6.
21. Verdon R, Pol S, Landais P, Mattlinger B, Camot F, Brechot C, et al. Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialyzed patients. J Hepatol 1994;21:388-93.
22. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-905.